Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention

Christopher P Kovach1, Annika Hebbe2, Thomas J Glorioso2

  • 1Division of Cardiology, Department of Medicine, University of Colorado, Aurora, Colorado, USA; Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.

Insights

Residual ischemic disease after percutaneous coronary intervention (PCI) significantly increases the risk of major adverse cardiovascular events (MACE). Automatically computed anatomic complexity scores can assess this risk and improve interventional quality.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Services Research

Background:

  • Anatomical scoring systems are used to assess revascularization completeness but are difficult to apply to large datasets.
  • The U.S. Department of Veterans Affairs (VA) health care system provides a large real-world dataset for analysis.

Purpose of the Study:

  • To assess the prevalence of complete revascularization.
  • To evaluate the association between complete revascularization and longitudinal clinical outcomes.
  • To utilize an automatically computed anatomic complexity score for this assessment.

Main Methods:

  • A cohort of 57,476 veterans undergoing percutaneous coronary intervention (PCI) between 2007 and 2020 was identified.
  • The VA SYNTAX score was used to quantify ischemic disease burden before and after PCI.
  • The association between residual VA SYNTAX score and major adverse cardiovascular events (MACE) at long-term follow-up was analyzed.

Main Results:

  • Higher residual VA SYNTAX scores were associated with increased hazards of MACE and death at 3 years.
  • The hazard of MACE increased with residual disease, irrespective of baseline severity or presentation.
  • Complete revascularization (residual VA SYNTAX score = 0) was associated with better outcomes.

Conclusions:

  • Residual ischemic disease after PCI is strongly linked to long-term adverse clinical outcomes.
  • Automatically computed anatomic complexity scores can effectively assess longitudinal risk for residual ischemic disease.
  • These scores may be implemented to enhance the quality of interventional procedures.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
34
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
19